Table 1:

Patients and surgical characteristics

N	Age	cTNM	Induction therapy	WBB sector	Type of spine resection	Rib resection	Length of surgery (min)	Blood loss (ml)	Transfusion (CGR)	Hospital stay (day)	Complications	Histology	pTNM	Tumours margin	Recurrence	Data follow-up
1	57	T3N0M0	C	10–9	WC T1, T2, T3	I, II, III rib	300	400	2	50	Chylothorax, peritonitis	Adenocarcinoma	T3N2M0	R0	Local	Alive at 34 months
2	47	T4N0M0	CR	8–10	Hemivertebrectomy T2, T3, T4	II, III, IV, V rib	330	2500	4	14	Pneumonia	Adenocarcinoma	T4N0M0	R0	No	Alive at 66 months
3	65	T3N2M0	CR	8–10	WC T1, T2, T3	I, II, III rib	320	300	2	9	No	Adenosquamous	T3N1M0	R0	Brain adrenal metastasis	Death at 13 months
4	74	T4N1M0	CR	3–5	WC T2, T3	I, II, III, IV rib	250	100	0	11	Pleural effusion	Squamous cell	T3N0M0	R0	No	Alive at 59 month
5	50	T4N0M0	CR	8–10	Hemivertebrectomy T2, T3	II, III rib	300	1600	4	9	No	Poorly differentiated	T0N0M0	R0	No	Alive at 41 months
6	69	T4N0M0	None	7–9	Hemivertebrectomy T2, T3, T4 + TP T1, T5	I, II, III, IV, V rib	330	600	3	12	Air leakage	Adenocarcinoma	T4N0M0	R0	Brain bone metastasis	Death at 15 months
7	66	T4N0M0	C	8–10	Hemivertebrectomy T9, T10	VIII, IX, X, XI rib	375	500	2	9	No	Adenocarcinoma	T4N2M0	R0	Local	Alive at 40 months
8	59	T4N0M0	CR	8–10	Hemivertebrectomy T2, T3, T4	II, III, IV rib	330	300	0	12	Pleural effusion	Adenocarcinoma	T0N0M0	R0	No	Alive at 31 months
9	69	T4N0M0	CR	8–10	Hemivertebrectomy T1, T2, T3	I, II, III rib	300	200	0	8	No	Squamous cell	T3N0M0	R0	No	Alive at 18 months
10	54	T4N0M0	CR	3–5	WC T2, T3	II, III rib	320	150	0	6	No	Adenocarcinoma	T0N0M0	R0	No	Alive at 6 months

C: chemotherapy; CR: chemoradiotherapy; TP: Transverse process; WBB: Weinstein, Boriani and Biagini; WC: wedge corpectomy.